Connect with us

Spread & Containment

Jim Jordan Investigating Renewed DOJ, FBI Contacts With Big Tech, Amid Concerns Of Censorship Pressure

Jim Jordan Investigating Renewed DOJ, FBI Contacts With Big Tech, Amid Concerns Of Censorship Pressure

Authored by Ryan Morgan via The Epoch…

Published

on

Jim Jordan Investigating Renewed DOJ, FBI Contacts With Big Tech, Amid Concerns Of Censorship Pressure

Authored by Ryan Morgan via The Epoch Times (emphasis ours),

Chairman of the House Judiciary Committee Rep. Jim Jordan (R-Ohio) questions former special counsel Robert K. Hur as Hur testifies before the House Judiciary Committee in Washington on March 12, 2024. (Win McNamee/Getty Images)

House Judiciary Committee Chairman Jim Jordan (R-Ohio) sent a series of letters on Tuesday, seeking to stay current on the FBI and U.S. Justice Department officials’ efforts to communicate with and potentially sway the behavior of major technology companies like Google and Facebook.

The FBI and DOJ have come under past scrutiny for their outreach to major technology firms amid concerns these federal officials are pressuring or inducing social media platforms and search engines to censor or disrupt the spread of certain political views online. These concerns formed the basis for an ongoing federal lawsuit, originally filed as Missouri v. Biden, alleging officials within President Joe Biden’s administration had exercised their influence over technology companies to censor disfavored views on topics such as the 2020 election and COVID-19 under the guise of combatting misinformation and protecting against foreign election interference.

In a July 2023 ruling, U.S. District Judge Terry Doughty ruled that the plaintiffs in Missouri v. Biden were “likely to succeed on the merits” of their arguments that Biden administration officials used their government authority to silence opposing political views. Judge Doughty granted an injunction, momentarily blocking several federal agencies from contacting technology platforms in efforts to induce those private firms to censor or suppress content containing constitutionally protected speech.

Judge Doughty’s injunction was upheld at the appellate court level, but the U.S. Supreme Court lifted it last fall while the court considered arguments in the case.

The Supreme Court’s decision to stay the injunction allows federal agencies to resume contact with social media and internet search firms. Mr. Jordan said an FBI spokesperson had informed him on March 20 that the FBI’s Foreign Influence Task Force (FITF) had resumed communicating with major social media and technology companies regarding alleged foreign influence campaigns.

While federal agents are allowed to once again contact technology platforms about the content appearing on their sites and search engines, Mr. Jordan appears intent on keeping tabs on how those contacts play out.

On Tuesday, Mr. Jordan sent letters to Attorney General Merrick Garland and FBI Director Christopher Wray, asking them to turn over records of their contacts with Alphabet (which owns the Google search engine), Meta (which owns Facebook, Instagram, and Threads), X (formerly known as Twitter), Microsoft, Apple, Reddit, and Yahoo, on a continuing basis.

The Republican congressman said the FBI and DOJ should provide records for each interaction with the listed technology companies “but no later than two weeks after each DOJ or FBI meeting with social media and technology companies takes place.”

Mr. Jordan is looking to monitor some of these interactions from both ends. He sent letters to Alphabet CEO Sundar Pichai, Amazon CEO Andy Jassy, Apple CEO Tim Cook, Meta CEO Mark Zuckerberg, and Microsoft CEO Satya Nadella, asking each technology executive to provide records within two weeks of interacting with the FBI.

Mr. Jordan, as the chairman of the House Judiciary Committee, issued subpoenas to the same technology executives last February. In his latest letters, the Republican congressman insisted those subpoenas were open-ended and required the covered technology companies, as well as the DOJ and FBI, to continue providing these records continuously.

NTD News reached out to the FBI and DOJ for comment but both government entities declined to comment on the matter.

NTD News also reached out to Alphabet, Amazon, Apple, Meta, and Microsoft. None of the technology firms responded by press time.

Biden Admin Insists Big Tech Contacts Not ‘Coercive’

The Supreme Court heard oral arguments last month in the ongoing litigation over the Biden administration’s contacts with major technology platforms. The Biden administration has argued in the case, now known as Murthy v. Missouri, that various federal officials contacting technology firms about potential disinformation has a legitimate function of government and has not involved a direct violation of people’s free speech rights.

Arguing the Biden administration’s case, Principal Deputy U.S. Solicitor General Brian Fletcher argued the allegations that the administration unduly influenced technology firms to censor and suppress constitutionally protected speech comes down to the distinction between persuasion and coercion.

Mr. Fletcher said government officials “may not use coercive threats to suppress speech” but were legally safe to continue “informing, persuading, or criticizing private speakers.”

Justice Samuel Alito pushed back on Mr. Fletcher’s line of argument during the March 18 hearing, noting a power imbalance in the interactions as the federal government has the authority to regulate the very same technology firms it was reaching out to with requests for censorship action. Justice Alito noted existing regulatory laws, like Section 230 of the Communications Decency Act and various antitrust laws federal actors might cite to potentially punish disfavored technology firms.

[The Federal government has] these big clubs available to it and so it’s treating Facebook and these other platforms like their subordinates,” Justice Alito said.

Mr. Fletcher said there at times appeared to be an “unusual” level of intensity and anger directed by government officials at technology firms as they pressed for certain content moderation decisions, but said that anger stemmed from a perception by the government actors that these technology firms were publicly claiming to want to help prevent the spread of misinformation but behind the scenes were “not being transparent about the scope of the problem.”

Tyler Durden Thu, 04/11/2024 - 15:20

Read More

Continue Reading

International

Tracking ticks in Georgia to help monitor emerging diseases

The most common tick found on humans in Georgia is the lone star tick — an aggressive seeker of blood that can spread dangerous pathogens through its…

Published

on

The most common tick found on humans in Georgia is the lone star tick — an aggressive seeker of blood that can spread dangerous pathogens through its bites.

Credit: Emory University

The most common tick found on humans in Georgia is the lone star tick — an aggressive seeker of blood that can spread dangerous pathogens through its bites.

Emory University researchers combined field data with spatial-analysis techniques to map the distribution of the lone star tick across the state. The journal Parasites & Vectors published the research, which identifies specific environmental conditions associated with this tick species, Amblyomma americanum, in Georgia.

The areas with the highest probability for the presence of lone star ticks include parts of the Southeastern Plains and Piedmont ecoregions of the state, including metro Atlanta.

“We found that these regions contain sweet spots for the lone star tick,” says Stephanie Bellman, first author of the study and an MD/PhD student in Emory’s School of Medicine and Rollins School of Public Health. “They tend to be more prevalent in forested areas of mid-elevation — not too high or too low — and in soils that retain moisture but are not swampy.”

The study maps the distribution at the scale of one square kilometer. That resolution is far finer than the currently available information, which is limited to the county level and does not encompass the state.

“As the weather warms and people start getting into the outdoors more, we hope our data can be used to target areas for tick-bite prevention messaging,” says Gonzalo Vazquez-Prokopec, professor in Emory’s Department of Environmental Sciences and senior author of the study.

Vazquez-Prokopec is a leading expert in vector-borne diseases — infections transmitted among humans and animals by the bite of a living organism, such as a tick or a mosquito.

Diseases the lone star tick is known to transmit include ehrlichiosis, southern tick-associated rash illness (STARI) and Heartland virus disease — which was first identified in the United States in 2009. The bite of the lone star tick is also associated with a potentially life-threatening allergy to red meat and dairy products known as alpha-gal syndrome.

Mapping the lone star tick is another step in a comprehensive Emory project to track and monitor the array of tick species in Georgia and the diseases that they can spread — including those caused by emerging pathogens.

Tickborne diseases are on the rise, far surpassing the incidence of diseases spread by mosquitos in the United States. While Lyme disease is the most common, the Centers for Disease Control and Prevention (CDC) currently recognizes 18 tickborne diseases in the country.

“We need to educate people that the environment that they grew up in is likely very different in terms of the number and types of ticks and the pathogens that they are carrying,” Vazquez-Prokopec says.

Climate change is fueling warmer and shorter winters, increasing opportunities for some species of ticks to breed more frequently and expand their ranges. Land-use changes are also strongly associated with tickborne diseases, as more human habitats encroach on wooded areas and the loss of natural habitat forces wildlife to live in denser populations.

“Georgia is a tick haven in general,” Bellman says, “since we have a long warm season and such a diversity of habitats.”

The researchers decided to focus first on mapping the distribution of the lone star tick because it is the dominant tick species in Georgia and can spread an array of pathogens. In 2019, the Emory researchers found that Heartland virus is circulating in lone star ticks in Georgia, an emerging pathogen that is not well understood.

Named for a bright, yellowish-white spot on its back, the lone star tick is widely distributed in wooded areas across the Southeast, Eastern and Midwest United States. It is tiny —in the nymph stage it is about the size of a sesame seed and as an adult it is barely a quarter-of-an-inch in diameter as an adult.

Despite its tiny size, the lone star tick is aggressive in its quest for blood meals. “They can sense carbon dioxide from your exhaled breath and the vibrations from your movement in a forest,” Bellman says. “They climb up onto vegetation and reach out their legs to grab onto you as you pass by.”

For the current study, Bellman led crews of Emory students, known as “the tick team,” in field surveys. They used “flagging” as a tick-collection technique. A white flannel cloth attached to a pole is swished in a figure-eight motion through the underbrush. Tweezers are used to transfer any ticks found on the flannel into a vial.

Tick team members surveyed 198 locations at 43 state parks and wildlife management areas across the state, from March to July 2022. Analyses combined the site-sampling data with environmental variables — including type of vegetation, land use, climate, elevation and other factors — characteristic for six different ecoregions of Georgia.

Lone star ticks were found in all of the ecoregions except for the mountainous Blue Ridge ecoregion in the northeast corner of the state. The majority of the ticks were found in forested areas of the Piedmont, Southeastern Plains and Southern Coastal Plains ecoregions.

The researchers encourage people to follow the recommendations of the CDC for preventing tick bites. And while the map for the lone star tick provides guidance on the likelihood of encountering the most prevalent human-biting tick in the state, there are other tick species that the researchers have yet to map.

The black-legged tick (Ixodes scapularis), which can transmit the bacterium that causes Lyme disease, for instance, is also established in Georgia. Lyme disease, however, is relatively uncommon in in the state for reasons that are not yet well-understood.

The researchers are also investigating the Asian longhorned tick (Haemaphysalis longicornis) in Georgia. Long established in China, Japan, Russia and parts of the Pacific, the Asian longhorned tick was first detected in the United States in 2017, in New Jersey, and has since spread to 19 states. It was found on farm animals in Pickens County, Georgia in 2021.

The Asian longhorned tick reproduces asexually and a single female can generate as many as 100,000 eggs, rapidly producing massive amounts of offspring that feed on livestock. So many ticks can be covering a single sheep or cow that the loss of blood physically weakens or, in extreme cases, kills the animal.

While it is often associated with livestock, the Emory research team recently found Asian longhorned ticks in the Buck Shoals Wildlife Management Area in White County, Georgia.

The Asian longhorned tick carries bacterial and viral pathogens that can infect humans, including severe fever with thrombocytopenia syndrome virus (SFTSV), also known as Dabie bandavirus. Human cases of SFTS, a hemorrhagic fever, emerged in China in 2009 and have since been identified in other parts of Asia, although not in the United States.

Also of concern is the fact that the Heartland virus shares genomic similarities with SFTS, which suggests the Asian longhorn tick could potentially transmit this emerging pathogen.

The Emory team has been finding the Heartland virus in lone star ticks collected from central Georgia starting in 2019. They have continued to find Heartland virus in at least some of the ticks collected from that area nearly annually through 2023. (They did not perform collections in 2020 due to the COVID-19 pandemic.)

More than 60 cases of Heartland virus disease have been reported in the United States, according to the latest CDC statistics. Many of the identified cases were severe enough to require hospitalization, and a few individuals with co-morbidities have died.

The actual number of people who may have been infected with Heartland virus is believed to be higher, however, since the virus is not well known and tests are rarely ordered for it. Complicating the issue is the fact that symptoms of Heartland virus are akin to those of many tickborne illnesses: fever, fatigue, headache, nausea, diarrhea and muscle or joint pain.

“Human cases of Heartland virus are rare now, but we don’t know whether that could change,” Bellman says. “We need to gather more baseline data and learn how it spreads in the environment so that we have the evidence we need to potentially prevent, or limit, its spread.”

Anne Piantadosi, assistant professor in Emory School of Medicine’s Department of Pathology and Laboratory Medicine, is co-author of the study.

Co-authors also include five Emory students who conducted fieldwork: Ellie Fausett (who has since graduated with a joint environmental sciences/MPH degree); Leah Aeschleman and Audrey Long (who have since received master’s of public health degrees from Rollins School of Public Health); Josie Pilchik, (who graduated with a bachelor’s in biology) and Isabella Roeske (an Emory senior majoring in environmental sciences).

Work on the current paper was funded by grants from the U.S. Department of Agriculture, National Institutes of Health, Emory University and the Emory MP3 Initiative and Infectious Disease Across Scales Training Program.


Read More

Continue Reading

International

Euro Extends Decline After ECB Holds Rates At Highs, Hints At Cuts To Come

Euro Extends Decline After ECB Holds Rates At Highs, Hints At Cuts To Come

After yesterday’s US CPI print – and the dramatic adjustment to…

Published

on

Euro Extends Decline After ECB Holds Rates At Highs, Hints At Cuts To Come

After yesterday's US CPI print - and the dramatic adjustment to market expectations of Fed policy action (timing and extent) - this morning's ECB was expected to be a nothing-burger with all eyes out for any confirmation that June is 'go-time' for Lagarde to cut (albeit a rare occurrence without a concomitant Fed cut) - which she will likely push her to stress the ECB's independence from The Fed.

Indeed, as expected, The ECB held rates at record highs for a fifth straight meeting.

The ECB added a new opening line to the statement:

“The Governing Council’s future decisions will ensure that its policy rates will stay sufficiently restrictive for as long as necessary..."

And it appears The ECB is laying the groundwork for a rate-cut sooner than later...

If the Governing Council’s updated assessment of the inflation outlook, the dynamics of underlying inflation and the strength of monetary policy transmission were to further increase its confidence that inflation is converging to the target in a sustained manner, it would be appropriate to reduce the current level of monetary policy restriction.”

One notable change in the statement, from this...

“The Governing Council’s future decisions will ensure that policy rates will be set at sufficiently restrictive levels for as long as necessary.”

...to this...

“The Governing Council’s future decisions will ensure that its policy rates will stay sufficiently restrictive for as long as necessary.”

Suggesting something is about to change.

Finally, The ECB reports that most measures of underlying inflation are easing.

Wage growth is moderating and firms are absorbing parts of these costs in their profits.

But, it says, domestic price pressures continue to be strong.

In short, the ECB remains data-dependent and isn’t committing to anything but if the progress of inflation and other factors has progressed sufficiently by June’s forecasts than reducing the level of policy restriction “would be appropriate”.

Not much movement in the bond space but the euro extended losses modestly on the ECB news...

Source: Bloomberg

As The FT notes, some eurozone policymakers, as in the UK, may want to avoid cutting rates much more aggressively than their counterparts in the US, partly out of fear of weakening their currencies and so further stoking inflation. But Peter Schaffrik, a strategist at RBC Capital Markets, said:

“The ECB has nailed its colours to the mast and shifting the guidance at this stage when actual inflation numbers are currently not far away from their own forecasts seems difficult to imagine.”

Now, we wait to see what Christine Lagarde says in the presser. You can bet someone a warm beer that she raises the fact that the ECB is independent of The Fed (when everyone knows, she is ultimately beholden to what Powell says and does)...

Read the full statement below:

The Governing Council today decided to keep the three key ECB interest rates unchanged. The incoming information has broadly confirmed the Governing Council’s previous assessment of the medium-term inflation outlook. Inflation has continued to fall, led by lower food and goods price inflation. Most measures of underlying inflation are easing, wage growth is gradually moderating, and firms are absorbing part of the rise in labour costs in their profits. Financing conditions remain restrictive and the past interest rate increases continue to weigh on demand, which is helping to push down inflation. But domestic price pressures are strong and are keeping services price inflation high.

The Governing Council is determined to ensure that inflation returns to its 2% medium-term target in a timely manner. It considers that the key ECB interest rates are at levels that are making a substantial contribution to the ongoing disinflation process. The Governing Council’s future decisions will ensure that its policy rates will stay sufficiently restrictive for as long as necessary. If the Governing Council’s updated assessment of the inflation outlook, the dynamics of underlying inflation and the strength of monetary policy transmission were to further increase its confidence that inflation is converging to the target in a sustained manner, it would be appropriate to reduce the current level of monetary policy restriction. In any event, the Governing Council will continue to follow a data-dependent and meeting-by-meeting approach to determining the appropriate level and duration of restriction, and it is not pre-committing to a particular rate path.

Key ECB interest rates
The interest rate on the main refinancing operations and the interest rates on the marginal lending facility and the deposit facility will remain unchanged at 4.50%, 4.75% and 4.00% respectively.

Asset purchase programme (APP) and pandemic emergency purchase programme (PEPP)
The APP portfolio is declining at a measured and predictable pace, as the Eurosystem no longer reinvests the principal payments from maturing securities.

The Governing Council intends to continue to reinvest, in full, the principal payments from maturing securities purchased under the PEPP during the first half of 2024. Over the second half of the year, it intends to reduce the PEPP portfolio by €7.5 billion per month on average. The Governing Council intends to discontinue reinvestments under the PEPP at the end of 2024.

The Governing Council will continue applying flexibility in reinvesting redemptions coming due in the PEPP portfolio, with a view to countering risks to the monetary policy transmission mechanism related to the pandemic.

Refinancing operations
As banks are repaying the amounts borrowed under the targeted longer-term refinancing operations, the Governing Council will regularly assess how targeted lending operations and their ongoing repayment are contributing to its monetary policy stance.

***

The Governing Council stands ready to adjust all of its instruments within its mandate to ensure that inflation returns to its 2% target over the medium term and to preserve the smooth functioning of monetary policy transmission. Moreover, the Transmission Protection Instrument is available to counter unwarranted, disorderly market dynamics that pose a serious threat to the transmission of monetary policy across all euro area countries, thus allowing the Governing Council to more effectively deliver on its price stability mandate.

The President of the ECB will comment on the considerations underlying these decisions at a press conference starting at 14:45 CET today.

Tyler Durden Thu, 04/11/2024 - 08:27

Read More

Continue Reading

Spread & Containment

Popular Paper On Ivermectin And COVID-19 Contains False Information

Popular Paper On Ivermectin And COVID-19 Contains False Information

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

A popular…

Published

on

Popular Paper On Ivermectin And COVID-19 Contains False Information

Authored by Zachary Stieber via The Epoch Times (emphasis ours),

A popular study that claims ivermectin has shown no effectiveness against all-cause mortality contains false information but remains uncorrected.

The meta-analysis, published in 2021 by the journal Clinical Infectious Diseases, explores how groups in randomized, controlled trials fared after receiving ivermectin compared to control groups.

Among five trials included for the portion on all-cause mortality, none showed an effect for ivermectin, the authors claimed.

Ivermectin “did not reduce all-cause mortality,” they wrote.

But the claim is wrong. One of the five trials was described as finding ivermectin recipients were more likely to die, but actually found that ivermectin recipients were less likely to die. “The risk base estimation ... confirmed that the average mortality obtained in all of ivermectin treated arms was 3.3%, while it was about 18.3% in standard care and placebo arms,” the authors of that paper said.

Dr. Adrian Hernandez, an associate professor at the University of Connecticut’s School of Pharmacy, and other authors of the meta-analysis are aware of the false information. The group released their study as a preprint before the journal published it. The first version included the false information. A corrected version properly portrayed the trial’s results for all-cause mortality in a figure summarizing the results, but still falsely said none of the trials showed a benefit against all-cause mortality.

Dr. Hernandez and Clinical Infectious Diseases did not respond to requests for comment.

The lingering false information is in a paper that has attracted numerous citations in other studies, in the press, and on social media. Altmetric, which tracks engagement, scores it at 5,900. A score of 20 or means a paper is doing “far better than most of its contemporaries,” according to the company.

Morimasa Yagisawa of Kitasato University and other researchers pointed out the issue in a March review of ivermectin trials, saying they were “concerned about the spread of misinformation and/or disinformation” about trial results.

“The articles on systematic reviews and meta-analyses are often erroneous or misleading. This is perhaps because the authors were not involved in the clinical trials or patient care and only searched for and analyzed articles and databases on clinical trial results,” they wrote. The problems are “particularly serious” in the paper for which Dr. Hernandez was the corresponding author, the researchers said.

Although it was a clear error, the wrong content of the preprint was published as a major article in Clinical Infectious Diseases, the official journal of the Infectious Diseases Society of America, without being changed,” they wrote. “Many comments were made questioning the insight of the reviewers and the Editor-in-Chief for publishing a paper with such inconsistencies, but the paper is still published without correction. Since this is a prestigious journal of a prestigious society, an early corrective action is required.”

“There have been several fraudulent meta-analyses, and this is a striking one,” Dr. Pierre Kory, president and chief officer of the FLCCC Alliance and author of the book The War on Ivermectin, told The Epoch Times in an email.

In this meta-analysis, they selected only 10 of the 81 controlled trials, 33 of which were randomized, on ivermectin that were available at the time. Eight of the ten they selected involved mild COVID-19. Typically, mild COVID does not lead to death. And here they were looking at death rates and, as expected, saw very few. The inclusion criteria they used were intended to show no effect. And they succeeded. Conflicted researchers have been doing this to hydroxychloroquine and ivermectin since the beginning of the pandemic,” he added.

Issues in other meta-analyses include the improper inclusion of papers that did not describe clinical trial results, Mr. Yagisawa and his co-authors said.

They noted that a number of trials have found ivermectin recipients were better off. That includes trials cited by the U.S. Food and Drug Administration (FDA) in its position that ivermectin is not effective against COVID-19.

The FDA recently settled a lawsuit over that position, agreeing to take down several web pages and social media posts.

Tyler Durden Wed, 04/10/2024 - 19:00

Read More

Continue Reading

Trending